2025 Silent Capital Report now available. Where family offices and LPs are actually deploying. [Download for free →]
About usSign in

Genesys University Seed Fund

Status
ACTIVE
Global HQ
Toronto, Canada
Countries of investment
  • Canada
Investment stages
  • Pre-Seed
  • Seed
Industries
  • Life Sciences
  • Biotechnology
  • Pharma
  • MedTech
  • Medical Devices
  • Diagnostics
About
Genesys University Seed Fund is a Toronto-based venture capital firm focused on backing early-stage life sciences spinouts from University of Toronto and McMaster University. Their focus spans life sciences, biotech, medical devices, therapeutics, and drug development across Canada. The firm supports university-affiliated life sciences founders from pre-seed through seed stages.
Min check size
$70K
Max check size
$710K
Fund size
NPS

Investment Thesis

Genesys University Seed Fund is a pre-seed and seed stage venture capital firm deploying capital across life sciences, biotech, medical devices, therapeutics, drug development, cancer treatment, and cardiovascular sectors. They invest up to $1M per startup in 10 to 15 university-affiliated life sciences companies, with up to $5M reserved for follow-on into biggest winners. The firm differentiates itself as the first venture fund anchored by University of Toronto and McMaster University, backed by Venture Ontario, Temerty Group, and RBC, modeled after MIT, UPenn, UC Berkeley, and Harvard university venture funds.
Lead investor
Co Invest
Number of exits
Preferred contact method

Manager's Experience

Co-founded by Kelly Holman and Damian Lamb (both Managing Directors), with Jamie Stiff (Managing Director), Jennifer Williams (Partner and Chief Financial Officer), Sarah Farr (Principal) and associates Stephanie Legere and Laurie Mak. Notable exits include Fusion Pharmaceuticals (acquired by AstraZeneca for $2.4B) and Inversago Pharma (acquired by Novo Nordisk for $1.1B). Portfolio includes Profound Medical, Adapsyn Bioscience, Antegrade Medical, EBT Medical and Flosonics Medical. Based in Toronto and focused on healthcare and life sciences.

Genesys University Seed Fund Contacts Information

Primary contact

Secondary contact

Team

Kelly Holman - Managing Director

Jennifer Williams - Partner & CFO

Portfolio

Adapsyn Bioscience

Antegrade Medical

Bios Genomics

CryoStasis

EBT Medical

Enspire DBS Therapy

Feldan Therapeutics

Flosonics Medical

Profound Medical

Veralox Therapeutics

Fund number
Year Founded
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp